Global Multiple Sclerosis Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4788603
- 89 Pages
- January 2022
- Pharmaceuticals
The United States Multiple Sclerosis Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Multiple Sclerosis Therapeutics market, reaching US$ million by the year 2028. As for the Europe Multiple Sclerosis Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Multiple Sclerosis Therapeutics players cover Novartis, Teva Pharmaceuticals, Sanofi Genzyme, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Multiple Sclerosis Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Beta Interferon
Corticosteroids
Monoclonal Antibodies
Antineoplastic Agents
Others
Segmentation by distribution channel: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
e-Commerce
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis
Teva Pharmaceuticals
Sanofi Genzyme
Bayer
Pfizer
Biogen Idec
Merck
AbbVie
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multiple Sclerosis Therapeutics Market Size 2017-2028
2.1.2 Multiple Sclerosis Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Multiple Sclerosis Therapeutics Segment by Type
2.2.1 Beta Interferon
2.2.2 Corticosteroids
2.2.3 Monoclonal Antibodies
2.2.4 Antineoplastic Agents
2.2.5 Others
2.3 Multiple Sclerosis Therapeutics Market Size by Type
2.3.1 Multiple Sclerosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Multiple Sclerosis Therapeutics Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 e-Commerce
2.5 Multiple Sclerosis Therapeutics Market Size by Distribution Channel
2.5.1 Multiple Sclerosis Therapeutics Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028)
2.5.2 Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022)
3 Multiple Sclerosis Therapeutics Market Size by Player
3.1 Multiple Sclerosis Therapeutics Market Size Market Share by Players
3.1.1 Global Multiple Sclerosis Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Multiple Sclerosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Multiple Sclerosis Therapeutics by Regions
4.1 Multiple Sclerosis Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Multiple Sclerosis Therapeutics Market Size Growth (2017-2022)
4.3 APAC Multiple Sclerosis Therapeutics Market Size Growth (2017-2022)
4.4 Europe Multiple Sclerosis Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Multiple Sclerosis Therapeutics Market Size by Country (2017-2022)
5.2 Americas Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
5.3 Americas Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multiple Sclerosis Therapeutics Market Size by Region (2017-2022)
6.2 APAC Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
6.3 APAC Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Multiple Sclerosis Therapeutics by Country (2017-2022)
7.2 Europe Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
7.3 Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multiple Sclerosis Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Multiple Sclerosis Therapeutics Market Forecast
10.1 Global Multiple Sclerosis Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Multiple Sclerosis Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Multiple Sclerosis Therapeutics Forecast
10.1.3 APAC Multiple Sclerosis Therapeutics Forecast
10.1.4 Europe Multiple Sclerosis Therapeutics Forecast
10.1.5 Middle East & Africa Multiple Sclerosis Therapeutics Forecast
10.2 Americas Multiple Sclerosis Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Multiple Sclerosis Therapeutics Market Forecast
10.2.2 Canada Multiple Sclerosis Therapeutics Market Forecast
10.2.3 Mexico Multiple Sclerosis Therapeutics Market Forecast
10.2.4 Brazil Multiple Sclerosis Therapeutics Market Forecast
10.3 APAC Multiple Sclerosis Therapeutics Forecast by Region (2023-2028)
10.3.1 China Multiple Sclerosis Therapeutics Market Forecast
10.3.2 Japan Multiple Sclerosis Therapeutics Market Forecast
10.3.3 Korea Multiple Sclerosis Therapeutics Market Forecast
10.3.4 Southeast Asia Multiple Sclerosis Therapeutics Market Forecast
10.3.5 India Multiple Sclerosis Therapeutics Market Forecast
10.3.6 Australia Multiple Sclerosis Therapeutics Market Forecast
10.4 Europe Multiple Sclerosis Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Multiple Sclerosis Therapeutics Market Forecast
10.4.2 France Multiple Sclerosis Therapeutics Market Forecast
10.4.3 UK Multiple Sclerosis Therapeutics Market Forecast
10.4.4 Italy Multiple Sclerosis Therapeutics Market Forecast
10.4.5 Russia Multiple Sclerosis Therapeutics Market Forecast
10.5 Middle East & Africa Multiple Sclerosis Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Multiple Sclerosis Therapeutics Market Forecast
10.5.2 South Africa Multiple Sclerosis Therapeutics Market Forecast
10.5.3 Israel Multiple Sclerosis Therapeutics Market Forecast
10.5.4 Turkey Multiple Sclerosis Therapeutics Market Forecast
10.5.5 GCC Countries Multiple Sclerosis Therapeutics Market Forecast
10.6 Global Multiple Sclerosis Therapeutics Forecast by Type (2023-2028)
10.7 Global Multiple Sclerosis Therapeutics Forecast by Distribution Channel (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Multiple Sclerosis Therapeutics Product Offered
11.1.3 Novartis Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Information
11.2.2 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product Offered
11.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Pharmaceuticals Main Business Overview
11.2.5 Teva Pharmaceuticals Latest Developments
11.3 Sanofi Genzyme
11.3.1 Sanofi Genzyme Company Information
11.3.2 Sanofi Genzyme Multiple Sclerosis Therapeutics Product Offered
11.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sanofi Genzyme Main Business Overview
11.3.5 Sanofi Genzyme Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Multiple Sclerosis Therapeutics Product Offered
11.4.3 Bayer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Multiple Sclerosis Therapeutics Product Offered
11.5.3 Pfizer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Biogen Idec
11.6.1 Biogen Idec Company Information
11.6.2 Biogen Idec Multiple Sclerosis Therapeutics Product Offered
11.6.3 Biogen Idec Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Biogen Idec Main Business Overview
11.6.5 Biogen Idec Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Multiple Sclerosis Therapeutics Product Offered
11.7.3 Merck Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Multiple Sclerosis Therapeutics Product Offered
11.8.3 AbbVie Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
12 Research Findings and Conclusion
Table 1. Multiple Sclerosis Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Beta Interferon
Table 3. Major Players of Corticosteroids
Table 4. Major Players of Monoclonal Antibodies
Table 5. Major Players of Antineoplastic Agents
Table 6. Major Players of Others
Table 7. Multiple Sclerosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 10. Multiple Sclerosis Therapeutics Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 12. Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022)
Table 13. Global Multiple Sclerosis Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Multiple Sclerosis Therapeutics Revenue Market Share by Player (2020-2022)
Table 15. Multiple Sclerosis Therapeutics Key Players Head office and Products Offered
Table 16. Multiple Sclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Multiple Sclerosis Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Multiple Sclerosis Therapeutics Market Size Market Share by Regions (2017-2022)
Table 21. Americas Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Country (2017-2022)
Table 23. Americas Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 25. Americas Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 26. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022)
Table 27. APAC Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Region (2017-2022)
Table 29. APAC Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 31. APAC Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 32. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022)
Table 33. Europe Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Country (2017-2022)
Table 35. Europe Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 37. Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 38. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022)
Table 39. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Multiple Sclerosis Therapeutics
Table 46. Key Market Challenges & Risks of Multiple Sclerosis Therapeutics
Table 47. Key Industry Trends of Multiple Sclerosis Therapeutics
Table 48. Global Multiple Sclerosis Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Multiple Sclerosis Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Multiple Sclerosis Therapeutics Market Size Forecast by Distribution Channel (2023-2028) & ($ Millions)
Table 53. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Distribution Channel (2023-2028)
Table 54. Novartis Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 55. Novartis Multiple Sclerosis Therapeutics Product Offered
Table 56. Novartis Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Novartis Main Business
Table 58. Novartis Latest Developments
Table 59. Teva Pharmaceuticals Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 60. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product Offered
Table 61. Teva Pharmaceuticals Main Business
Table 62. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Teva Pharmaceuticals Latest Developments
Table 64. Sanofi Genzyme Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 65. Sanofi Genzyme Multiple Sclerosis Therapeutics Product Offered
Table 66. Sanofi Genzyme Main Business
Table 67. Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Sanofi Genzyme Latest Developments
Table 69. Bayer Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 70. Bayer Multiple Sclerosis Therapeutics Product Offered
Table 71. Bayer Main Business
Table 72. Bayer Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Bayer Latest Developments
Table 74. Pfizer Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 75. Pfizer Multiple Sclerosis Therapeutics Product Offered
Table 76. Pfizer Main Business
Table 77. Pfizer Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Pfizer Latest Developments
Table 79. Biogen Idec Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 80. Biogen Idec Multiple Sclerosis Therapeutics Product Offered
Table 81. Biogen Idec Main Business
Table 82. Biogen Idec Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Biogen Idec Latest Developments
Table 84. Merck Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 85. Merck Multiple Sclerosis Therapeutics Product Offered
Table 86. Merck Main Business
Table 87. Merck Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Merck Latest Developments
Table 89. AbbVie Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 90. AbbVie Multiple Sclerosis Therapeutics Product Offered
Table 91. AbbVie Main Business
Table 92. AbbVie Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. AbbVie Latest Developments
List of Figures
Figure 1. Multiple Sclerosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Multiple Sclerosis Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2021
Figure 7. Multiple Sclerosis Therapeutics in Hospital Pharmacies
Figure 8. Global Multiple Sclerosis Therapeutics Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Multiple Sclerosis Therapeutics in Retail Pharmacies
Figure 10. Global Multiple Sclerosis Therapeutics Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Multiple Sclerosis Therapeutics in e-Commerce
Figure 12. Global Multiple Sclerosis Therapeutics Market: e-Commerce (2017-2022) & ($ Millions)
Figure 13. Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021
Figure 14. Global Multiple Sclerosis Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Multiple Sclerosis Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Multiple Sclerosis Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Multiple Sclerosis Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021
Figure 23. United States Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021
Figure 29. China Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021
Figure 38. Germany Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021
Figure 46. Egypt Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
